EarningsIQ
Sectors Themes Calendar Create Free Account Sign In
User ▾
My Account Sign Out
Create Free Account Sign In
Hello, User My Account Sign Out
Sectors Themes Calendar

Invivyd, Inc. (IVVD) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

11/25
Growth 4 Margin 2 Expansion 3 Platform 0 Financial 2
latest quarter score

Earnings Reports

  • 11
    InVivid (IVVD) Q1 2026: Pemgarda Climbs 22% as Monoclonal Antibody Platform Expands Beyond COVID
    June 17, 2026
  • 14
    InVivid (IVVD) Q3 2025: $87M Capital Infusion Powers Pivotal Antibody Launch Path
    June 16, 2026
  • 12
    InVivid (IVVD) Q4 2025: Pemgarda Revenue Climbs 31% QoQ, Pivotal VYD2311 Data in Sight
    June 15, 2026
  • 8
    Invivyd (IVVD) Q1 2025: Internalized Sales Force Drives Early Q2 Revenue Acceleration Amid Pipeline Expansion
    May 15, 2025

Browse all companies

EarningsIQ

Strategic earnings insights for investors who want to understand what's happening beneath the chart.

Navigation

  • Home
  • Sectors
  • Themes
  • Calendar

Resources

  • About
  • Editorial Policy
  • Contact
  • Companies A–Z
  • Latest Analysis
  • Privacy
  • Terms

Subscribe

Get weekly earnings insights delivered to your inbox.

© 2025 EarningsIQ. All rights reserved.

×

Create Free Account

or

Already have an account? Sign in

By creating an account using any of the options above, you agree to the Terms of Use & Privacy Policy

Sharpen Your Earnings Edge

Stay aligned with how companies are performing, positioning, and evolving—quarter by quarter.

  • 📰
    Read compressed, insight-rich articles built from public company earnings calls.
  • 📊
    Explore analysis organized by company, sector, and strategic theme.
  • 📈
    Track executive priorities, performance signals, and market shifts—all in context.
  • ⭐
    Get fast reads that support sharper decisions across time horizon.
×

Sign In

or
Forgot password?

Don't have an account? Create free account